Literature DB >> 21224351

The first Tianjin, China forum on tumor microenvironment.

Evan T Keller1, Lu-Yuan Li.   

Abstract

Although it is well recognized that the tumor microenvironment plays a key role in regulating tumor progression, the mechanisms through which this occurs need to be defined. Current international research activities toward defining the role of the tumor microenvironment in cancer progression were the subject of the first Tianjin Forum on Tumor Microenvironment held at Nankai University in Tianjin, China, July 2 to 4, 2010. The importance of variety of processes, such as inflammation and angiogenesis, in the role of tumor progression was described for multiple tumor types including breast, prostate, and hepatic cancers, as well as the process of bone metastasis. Identification of novel signaling pathways that impact both angiogenesis and bone remodeling were presented. Several themes emerged from this meeting, such as: (i) tumor cells modify the microenvironment to enhance their own survival and progression; (ii) targeting host factors, in addition to targeting tumor cells, will have important therapeutic effects; and (iii) host cells distribution within the tumor has both prognostic and therapeutic significance. Several priorities for future research were defined including use of a systems biology approach to define the role of host factors in tumor progression, to define the importance of targeting both arms of the bone remodeling process for therapy of bone metastasis, and to determine how different cell subsets contribute to microenvironment-mediated regulation of tumor progression.
© 2011 AACR.

Entities:  

Mesh:

Year:  2011        PMID: 21224351      PMCID: PMC3075440          DOI: 10.1158/0008-5472.CAN-10-2930

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

Review 1.  Macrophage activation and polarization.

Authors:  Fernando Oneissi Martinez; Antonio Sica; Alberto Mantovani; Massimo Locati
Journal:  Front Biosci       Date:  2008-01-01

2.  Activating transcription factor 4 regulates osteoclast differentiation in mice.

Authors:  Huiling Cao; Shibing Yu; Zhi Yao; Deborah L Galson; Yu Jiang; Xiaoyan Zhang; Jie Fan; Binfeng Lu; Youfei Guan; Min Luo; Yumei Lai; Yibei Zhu; Noriyoshi Kurihara; Kenneth Patrene; G David Roodman; Guozhi Xiao
Journal:  J Clin Invest       Date:  2010-07-12       Impact factor: 14.808

3.  Prostate cancer cells promote osteoblastic bone metastases through Wnts.

Authors:  Christopher L Hall; Anna Bafico; Jinlu Dai; Stuart A Aaronson; Evan T Keller
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

4.  NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF.

Authors:  Bae Keun Park; Honglai Zhang; Qinghua Zeng; Jinlu Dai; Evan T Keller; Thomas Giordano; Keni Gu; Veena Shah; Lei Pei; Richard J Zarbo; Laurie McCauley; Songtao Shi; Shaoqiong Chen; Cun-Yu Wang
Journal:  Nat Med       Date:  2006-12-10       Impact factor: 53.440

Review 5.  The role of Wnts in bone metastases.

Authors:  Christopher L Hall; Evan T Keller
Journal:  Cancer Metastasis Rev       Date:  2006-12       Impact factor: 9.264

6.  U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia.

Authors:  W Xiao; Q Zhang; G Habermacher; X Yang; A-Y Zhang; X Cai; J Hahn; J Liu; M Pins; L Doglio; R Dhir; J Gingrich; Z Wang
Journal:  Oncogene       Date:  2007-09-17       Impact factor: 9.867

Review 7.  Bone and bone turnover.

Authors:  Patricia M Crofton
Journal:  Endocr Dev       Date:  2009-03-03

8.  Inhibition of endothelial progenitor cell differentiation by VEGI.

Authors:  Fang Tian; Paulina H Liang; Lu-Yuan Li
Journal:  Blood       Date:  2009-03-27       Impact factor: 22.113

Review 9.  Pathogenesis of myeloma bone disease.

Authors:  G D Roodman
Journal:  Leukemia       Date:  2008-11-27       Impact factor: 11.528

Review 10.  The role of the VEGF-C/VEGFR-3 axis in cancer progression.

Authors:  J-L Su; C-J Yen; P-S Chen; S-E Chuang; C-C Hong; I-H Kuo; H-Y Chen; M-C Hung; M-L Kuo
Journal:  Br J Cancer       Date:  2006-12-12       Impact factor: 7.640

View more
  3 in total

1.  The PCa Tumor Microenvironment.

Authors:  Joseph L Sottnik; Jian Zhang; Jill A Macoska; Evan T Keller
Journal:  Cancer Microenviron       Date:  2011-07-05

Review 2.  Immune mediators in the tumor microenvironment of prostate cancer.

Authors:  Jinlu Dai; Yi Lu; Hernan Roca; Jill M Keller; Jian Zhang; Laurie K McCauley; Evan T Keller
Journal:  Chin J Cancer       Date:  2017-03-14

3.  TLR4 ligand/H₂O₂ enhances TGF-β1 signaling to induce metastatic potential of non-invasive breast cancer cells by activating non-Smad pathways.

Authors:  Yuan-Hong Zhou; Sheng-Jun Liao; Dong Li; Jing Luo; Jing-Jing Wei; Bin Yan; Rui Sun; Yu Shu; Qi Wang; Gui-Mei Zhang; Zuo-Hua Feng
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.